Skip to main content

Year: 2021

D2L ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES

Toronto, Nov. 12, 2021 (GLOBE NEWSWIRE) — D2L Inc. (TSX: DTOL), a global learning technology leader, announced today participation in the following investor conferences:TD Securities Virtual Technology Conference: John Baker, President and CEO, and Melissa Howatson, Chief Financial Officer, will participate in an interactive virtual discussion on Monday, November 15, 2021, at 10:25 am ET. A live video webcast of the discussion will be available under the investor relations section of D2L’s website at ir.d2l.com/events-and-presentations/events/.KeyBanc Capital Markets Sector Spotlight: Education Technology: Mr. Baker will also be participating in a panel discussion at the KeyBanc EdTech Private Event on November 16, 2021.ABOUT D2L (TSX: DTOL) D2L is transforming the way the world learns—helping learners of all ages achieve...

Continue reading

Interpublic Group to Present at the Morgan Stanley European Technology, Media and Telecom Conference

New York, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the Morgan Stanley European Technology, Media & Telecom Conference on Wednesday, November 17th 2021, at 1:15 pm Eastern time, as scheduled. A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic’s website (http://investors.interpublic.com) where it will remain available for replay for 30 days. # # # About InterpublicInterpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include: Acxiom, Craft, FCB, FutureBrand, Golin, Huge, Initiative, Jack Morton, Kinesso, MAGNA,...

Continue reading

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team will participate at two upcoming virtual investor conferences, including: Guggenheim Healthcare Talks: 3rd Annual Neuro/Immunology ConferenceDate: November 16, 2021Live Webcast: 9:40 am EST Jefferies London Healthcare ConferenceDate: November 17, 2021Fireside Chat: 5:00 am EST / 10:00 am GMT Members of Phathom’s management team will also participate virtually in one-on-one meetings throughout the duration of each conference. To access the live webcast and archived recording of the presentations, visit the News & Events section of the Phathom...

Continue reading

Prudential Bancorp, Inc. Announces Fiscal 2021 Results

PHILADELPHIA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq:PBIP), the holding company for Prudential Bank (the “Bank”), reported net income of $2.0 million, or $0.26 per basic and $0.25 per diluted share, for the quarter ended September 30, 2021 as compared to $548,000, or $0.07 per basic and diluted share, for the same quarter in fiscal 2020. For the fiscal year ended September 30, 2021, the Company reported net income of $7.8 million, or $0.98 per basic and diluted share as compared to $9.6 million, or $1.12 per basic and diluted share, for fiscal 2020. Fiscal year 2020 included significant gains on sales of investment securities available for sale. Dennis Pollack, President and CEO, commented, “We are pleased to report improvement in both our net interest margin and interest rate spread,...

Continue reading

Atlanticus Reports Third Quarter 2021 Financial Results

Net Income Attributable to Common Shareholders Increases to $40.3 Million, or $1.96 per Share ATLANTA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for the third quarter ended September 30, 2021. Financial and Operating Highlights 2021 Third Quarter compared to 2020 Third QuarterTotal operating revenue increased 41.8% to $203.9 million. Purchase volume increased 55.7% to $610.5 million. The number of total customers we serve(1) increased 59.8% to 2.6 million. Since the start of the third quarter 2021, customers served increased by over 388,000,...

Continue reading

Quotient Limited to Participate in the Jefferies London Healthcare Conference

JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT (3:40am ET). A webcast of the presentation will be available online from the investor relations page of the Company’s corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days. About Quotient Limited Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully...

Continue reading

ETC Awarded $2.6 Million Contract for its Environmental Testing and Simulation Unit

SOUTHAMPTON, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Environmental Testing and Simulation Unit has been awarded a $2.6 million project to provide climatic test equipment for a major, multinational truck and bus manufacturer. This environmental simulation equipment will provide the customer the capability to simulate specific operating conditions including wide ranges of temperature, humidity, and altitude. These systems will be used to test various vehicle types including diesel, natural gas, hybrid, and full electric in the areas of emissions, product development, and regulatory compliance. About ETC: ETC designs, manufactures, and sells software driven products and services used to recreate and monitor the physiological effects of motion on humans,...

Continue reading

Nocopi’s Q3 Cash Position Improved 12% from June 2021 to $2.1M Despite Drop in Product Revenue Related to Customer Supply Chain Challenges, Names New Independent Director

KING OF PRUSSIA, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its third quarter and nine months ended September 30, 2021 (Q3’21 & 9M’21). Nocopi’s SEC filings are available here. Q3’21 Results Q3’21 revenue declined 59% to $312,500 reflecting a decrease in product and other sales, principally due to specialty ink shipments for licensees in the entertainment and toy product market. In contrast, license and royalty revenue rose 45% to $222,500 reflecting growth in royalty income from toy and entertainment market customers. Revenue from security market customers was relatively unchanged at approximately...

Continue reading

Seneca Foods Reports Sales and Earnings for the Six Months Ended October 2, 2021

MARION, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) — Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the second quarter and six months ended October 2, 2021. Executive Summary (vs. year-ago, second quarter results):Net sales for the second quarter of fiscal 2022 totaled $372.3 million compared to $390.3 million in the second quarter of fiscal 2021. Gross margin as a percentage of net sales for the second quarter is 11.5% in 2022 as compared to 12.5% in 2021.Commenting on the results, Paul Palmby, President and Chief Executive Officer of Seneca Foods, stated, “We are pleased with the Company’s performance in the second quarter.  A comparative perspective to the prior year remains a challenge given the 2020 COVID-19 pantry loading and the Truitt divestiture that happened in fiscal year 2021. However,...

Continue reading

Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today announced results for the quarter ended September 30, 2021, and provided a business update. Highlights of the quarter and recent weeks include:Successful completion of the Company’s public listing (Nasdaq: JSPR) on September 27, 2021 following the business combination with Amplitude Healthcare Acquisition Corporation (AMHC) on September 24, 2021 Receipt of $100 million in gross proceeds through the closing of the concurrent companion PIPE transaction Enrollment of JSP191 Phase 1b study expansion cohorts in acute myeloid leukemia/myelodysplastic syndrome (AML/MDS) on track; top-line interim data expected Q1 2022 JSP191 Phase 1b severe combined immunodeficiency...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.